Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Santen Pharmaceutical Co Ltd
TSE:4536
Santen Pharmaceutical Co Ltd
TSE:4536
Price:
1 645.5
JPY
-2.89%
Market Closed
Market Cap:
¥530.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Santen Pharmaceutical Co Ltd
TSE:4536
|
JP |
|
E
|
Endeavour Silver Corp
F:EJD
|
CA |
|
N
|
Nkt A/S
CSE:NKT
|
DK |
|
W
|
Wasko SA
WSE:WAS
|
PL |
Wall St Price Targets
Price Forecast
Based on 10 analysts
Based on 10 analysts
+44% Upside
from
¥1 645.5
today
Santen Pharmaceutical Co Ltd (4536)’s 12-month stock price forecast through October 2027 has a consensus target of ¥2 371.5, implying 44% upside. The forecast is based on price targets from 10 Wall Street analysts.
Analyst Rating
No ratings yet
No ratings yet
Santen Pharmaceutical Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Santen Pharmaceutical Co Ltd's stock price target?
Price Target
2 371.5
JPY
2 371.5
JPY
According to Wall Street analysts, the average 1-year price target for Santen Pharmaceutical Co Ltd is 2 371.5 JPY with a low forecast of 1 919 JPY and a high forecast of 2 940 JPY.
What is the Revenue forecast for Santen Pharmaceutical Co Ltd?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Santen Pharmaceutical Co Ltd?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Santen Pharmaceutical Co Ltd?
Projected CAGR
29%
29%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 1 year is 29%.
What is the Pre-Tax Income forecast for Santen Pharmaceutical Co Ltd?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 5%. The projected CAGR for the next 3 years is 9%.
What is the Net Income forecast for Santen Pharmaceutical Co Ltd?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 8%.